Owl Creek Wealth Partners’s ADMA Biologics ADMA Stock Holding History

Owl Creek Wealth Partners’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.77K	Buy	+450	New	+$4.1K	﹤0.01%	1082

Other funds holding ADMA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Owl Creek Wealth Partners's ADMA Position: Q2 2026 in Review

Owl Creek Wealth Partners opened a new position in ADMA Biologics (ADMA) in Q2 2026: 450 shares worth $3.77K. The stake represents ﹤0.01% of the portfolio and ranks #1082 among its holdings.

302 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

Owl Creek Wealth Partners held 450 shares of ADMA Biologics worth $3.77K as of Q2 2026.
ADMA Biologics was a new Owl Creek Wealth Partners position in Q2 2026.
ADMA Biologics made up ﹤0.01% of Owl Creek Wealth Partners's portfolio in Q2 2026, its #1082 holding.
302 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Owl Creek Wealth Partners's 13F filing for Q2 2026, filed 20 Jul 2026.